|
1
|
Chen X, Du J, Huang J, Zeng Y and Yuan K:
Neoadjuvant and adjuvant therapy in intrahepatic
cholangiocarcinoma. J Clin Transl Hepatol. 10:553–563. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Halder R, Amaraneni A and Shroff RT:
Cholangiocarcinoma: A review of the literature and future
directions in therapy. Hepatobiliary Surg Nutr. 11:555–566. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kubo S, Shinkawa H, Asaoka Y, Ioka T,
Igaki H, Izumi N, Itoi T, Unno M, Ohtsuka M, Okusaka T, et al:
Liver cancer study group of Japan clinical practice guidelines for
intrahepatic cholangiocarcinoma. Liver Cancer. 11:290–314. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahmed Z, Mohamed K, Zeeshan S and Dong X:
Artificial intelligence with multi-functional machine learning
platform development for better healthcare and precision medicine.
Database (Oxford). 2020:baaa0102020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ibrahim I and Abdulazeez A: The role of
machine learning algorithms for diagnosing diseases. J Appl Sci
Technol Trend. 2:10–19. 2021. View Article : Google Scholar
|
|
6
|
Richens JG, Lee CM and Johri S: Improving
the accuracy of medical diagnosis with causal machine learning. Nat
Commun. 11:39232020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stenzinger A, Moltzen EK, Winkler E,
Molnar-Gabor F, Malek N, Costescu A, Jensen BN, Nowak F, Pinto C,
Ottersen OP, et al: Implementation of precision medicine in
healthcare-A European perspective. J Intern Med. 294:437–454. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee J, Yoo SK, Kim K, Lee BM, Park VY, Kim
JS and Kim YB: Machine learning-based radiomics models for
prediction of locoregional recurrence in patients with breast
cancer. Oncol Lett. 26:4222023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zeng J, Zeng J, Lin K, Lin H, Wu Q, Guo P,
Zhou W and Liu J: Development of a machine learning model to
predict early recurrence for hepatocellular carcinoma after
curative resection. Hepatobiliary Surg Nutr. 11:176–187. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin L, Zhao Q, Fu S, Cao F, Hou B and Ma
J: Development and validation of machine learning models to predict
survival of patients with resected stage-III NSCLC. Front Oncol.
13:10924782023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Likhitrattanapisal S, Tipanee J and
Janvilisri T: Meta-analysis of gene expression profiles identifies
differential biomarkers for hepatocellular carcinoma and
cholangiocarcinoma. Tumour Biol. 37:12755–12766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu HY, Xia S, Liu AG, Wei MD, Chen ZB, Li
YX, He Y, Liao MJ, Hu QP and Pan SL: Upregulation of miR-132-3p in
cholangiocarcinoma tissues: A study based on RT-qPCR, the cancer
genome atlas miRNA sequencing, gene expression omnibus microarray
data and bioinformatics analyses. Mol Med Rep. 20:5002–5020.
2019.PubMed/NCBI
|
|
13
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372:n712021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van Tulder M, Furlan A, Bombardier C and
Bouter L; Editorial Board of the Cochrane Collaboration Back Review
Group, : Updated method guidelines for systematic reviews in the
cochrane collaboration back review group. Spine (Phila Pa 1976).
28:1290–1299. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
University of York Centre for Reviews and
Dissemination, . Jinatongthai P, Kongwatcharapong J, Phrommintikul
A, Nathisuwan S and Chaiyakunapruk N: Comparative efficacy and
safety of reperfusion therapy with fibrinolytic agents in patient
with ST-segment elevation myocardial infarction: A systematic
review and network meta-analysis. Prospero 2019: CRD42019161406.
2022.Available from:. https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=487932(date
of access, 18/01/2024).
|
|
16
|
Lo CK, Mertz D and Loeb M:
Newcastle-Ottawa Scale: comparing reviewers' to authors'
assessments. BMC Med Res Methodol. 14(45):
doi:10.1186/1471-2288-14-45. 2014.PubMed/NCBI
|
|
17
|
Salanti G, Del Giovane C, Chaimani A,
Caldwell DM and Higgins JPT: Evaluating the quality of evidence
from a network meta-analysis. PLoS One. 9:e996822014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang C, Xu C, Li X and Zhang Y, Zhang S,
Zhang T and Zhang Y: Could camrelizumab plus chemotherapy improve
clinical outcomes in advanced malignancy? A systematic review and
network meta-analysis. Front Oncol. 11:7001652021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang C, Han X, Jin M, Xu J, Wang Y, Zhang
Y, Xu C, Zhang Y, Jin E and Piao C: The effect of video game-based
interventions on performance and cognitive function in older
adults: Bayesian network meta-analysis. JMIR Serious Games.
9:e270582021. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nikolakopoulou A, Higgins JPT,
Papakonstantinou T, Chaimani A, Del Giovane C, Egger M and Salanti
G: CINeMA: An approach for assessing confidence in the results of a
network meta-analysis. PLoS Med. 17:e10030822020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alaimo L, Lima HA, Moazzam Z, Endo Y, Yang
J, Ruzzenente A, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, et
al: Development and validation of a machine-learning model to
predict early recurrence of intrahepatic cholangiocarcinoma. Ann
Surg Oncol. 30:5406–5415. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song Y, Zhou G, Zhou Y, Xu Y, Zhang J,
Zhang K, He P, Chen M, Liu Y, Sun J, et al: Artificial intelligence
CT radiomics to predict early recurrence of intrahepatic
cholangiocarcinoma: A multicenter study. Hepatol Int. 17:1016–1027.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jolissaint JS, Wang T, Soares KC, Chou JF,
Gönen M, Pak LM, Boerner T, Do RKG, Balachandran VP, D'Angelica MI,
et al: Machine learning radiomics can predict early liver
recurrence after resection of intrahepatic cholangiocarcinoma. HPB
(Oxford). 24:1341–1350. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo Q, Sun C, Chang Q, Wang Y, Chen Y,
Wang Q, Li Z and Niu L: Contrast-enhanced ultrasound-based nomogram
for predicting malignant involvements among sonographically
indeterminate/suspicious cervical lymph nodes in patients with
differentiated thyroid carcinoma. Ultrasound Med Biol.
48:1579–1589. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang W, Xu L, Yang P, Zhang L, Wan D,
Huang Q, Niu T and Chen F: Novel nomogram for preoperative
prediction of early recurrence in intrahepatic cholangiocarcinoma.
Front Oncol. 8:3602018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moris D, Palta M, Kim C, Allen PJ, Morse
MA and Lidsky ME: Advances in the treatment of intrahepatic
cholangiocarcinoma: An overview of the current and future
therapeutic landscape for clinicians. CA Cancer J Clin. 73:198–222.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang H, Yang T, Wu M and Shen F:
Intrahepatic cholangiocarcinoma: Epidemiology, risk factors,
diagnosis and surgical management. Cancer Lett. 379:198–205. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bu F, Deng XH, Zhan NN, Cheng H, Wang ZL,
Tang L, Zhao Y and Lyu QY: Development and validation of a risk
prediction model for frailty in patients with diabetes. BMC
Geriatr. 23:1722023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin J, Su H, Zhou Q, Pan J and Zhou L:
Predictive value of nomogram based on Kyoto classification of
gastritis to diagnosis of gastric cancer. Scand J Gastroenterol.
57:574–580. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chong HH, Yang L, Sheng RF, Yu YL, Wu DJ,
Rao SX, Yang C and Zeng MS: Multi-scale and multi-parametric
radiomics of gadoxetate disodium-enhanced MRI predicts
microvascular invasion and outcome in patients with solitary
hepatocellular carcinoma ≤5 cm. Eur Radiol. 31:4824–4838. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Zhang Z, Wei L and Wei S:
Construction and validation of nomograms combined with novel
machine learning algorithms to predict early death of patients with
metastatic colorectal. Front Public Health. 10:10081372022.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lei H, Li X, Ma W, Hong N, Liu C, Zhou W,
Zhou H, Gong M, Wang Y, Wang G and Wu Y: Comparison of nomogram and
machine-learning methods for predicting the survival of non-small
cell lung cancer patients. Cancer Innov. 1:135–145. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saleh H, Abd-El Ghany SF, Alyami H and
Alosaimi W: Predicting breast cancer based on optimized deep
learning approach. Comput Intell Neurosci. 2022:18207772022.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ghoniem RM, Algarni AD, Refky B and Ewees
AA: Multi-modal evolutionary deep learning model for ovarian cancer
diagnosis. Symmetry. 13:6432021. View Article : Google Scholar
|
